Imlygic 10e6

Imlygic 10e6 is a medicine authorised by Swissmedic under authorisation number 65812. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Transplant: gene therapy product and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 13 July 2016 and the authorisation is valid without a time limit. ATC code L01XL02 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 65812
  • ATC L01XL02
  • Transplant: gene therapy product
Authorisation data
Authorisation number65812
NameImlygic 10e6
Full nameImlygic 10e6, Injektionslösung
Authorisation holderAmgen Switzerland AG
Medicinal product codeTransplant: gene therapy product
Dispensing categoryA · Prescription, not repeatable
ATC codeL01XL02
First authorisation13 July 2016
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Imlygic 10e6, InjektionslösungA13 July 2016
2Imlygic 10e8, InjektionslösungA13 July 2016

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11 mlDurchstechflasche(n)L01XL0207.16.A
21 mlDurchstechflasche(n)L01XL0207.16.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Imlygic 10e6 authorised in Switzerland?

Yes. Imlygic 10e6 is authorised by Swissmedic under authorisation number 65812, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Imlygic 10e6 have?

Imlygic 10e6 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Imlygic 10e6?

The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com